Prescribing patterns of glucosamine in an older population: A national cohort study

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Galvin, Rose ^a   Cousins, Grainne ^a   Boland, Fiona ^a   Motterlini, Nicola ^a   Bennett, Kathleen ^b   Fahey, Tom ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cost effectiveness; Glucosamine; Osteoarthritis

Indexed keywords

GLUCOSAMINE;

AGE; AGED; ARTICLE; COHORT ANALYSIS; DRUG COST; FEMALE; GERIATRIC PATIENT; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; FEMALE; GLUCOSAMINE; HUMANS; MALE; OSTEOARTHRITIS; PRESCRIPTION DRUGS; PREVALENCE; REGRESSION ANALYSIS;

EID: 84887325166     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-316     Document Type: Article

References (25)

1. Facts about arthritis. http://www.arthritisireland.ie.
2. Seed S, Dunican K, Lynch AM. Osteoarthritis: a review of treatment options. Geriatrics 2009, 64(10):20-29.
3. Wandel S, Juni P, Tendal B, Nuesch E, Villiger P, Welton N, Reichenbach S, Trelle S. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 2010, 341:c4675. 10.1136/bmj.c4675, 2941572, 20847017.
4. Gigante A, Callegari L. The role of intra-articular hyaluronan (Sinovial) in the treatment of osteoarthritis. Rheumatol Int 2011, 31(4):427-444. 10.1007/s00296-010-1660-6, 21113807.
5. Towheed T, Maxwell L, Anastassiades TP, Shea B, Houpt JB, Welch V, Hochberg MC, Wells GA. Glucosamine therapy for treating osteoarthritis. Cochrane Database of Syst Rev 2005, 2. CD002946.
6. Vlad SC, LaValley MP, McAlindon TE, Felson DT. Glucosamine for pain in osteoarthritis: why do trial results differ?. Arthritis Rheum 2007, 56(7):2267-2277. 10.1002/art.22728, 17599746.
7. Lopez Fernandez JC, Ruano-Ravina A. Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review. Osteoarthritis Cartilage 2006, 14(12):1306-1311. 10.1016/j.joca.2006.08.003, 16979914.
8. Reichenbach S, Sterchi R, Scherer M, Trelle S, Burgi E, Burgi U, Dieppe PA, Juni P. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med 2007, 146(8):580-590. 10.7326/0003-4819-146-8-200704170-00009, 17438317.
9. National Institute for Health and Clinical Excellence Osteoarthritis: the care and management of osteoarthritis in adults 2008, London: National Collaborating Centre for Chronic Conditions, National Institute for Health and Clinical Excellence.
10. Richmond J, Hunter D, Irrgang J, Jones MH, Snyder-Mackler L, Van Durme D, Rubin C, Matzkin EG, Marx RG, Levy BA, et al. American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis (OA) of the knee. J Bone Joint Surg Am 2010, 92(4):990-993. 10.2106/JBJS.I.00982, 20360527.
11. US glucosamine grows slow, lags global sales. http://www.nutraingredients-usa.com/Markets/US-glucosamine-grows-slow-lags-global-sales.
12. Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prscribing and cost outcomes for older people: a national population study. B Clin Pharmacol 2010, 69(5):543-552.
13. Naughton C, Bennett K, Feely J. Prevalence of chronic disease in the elderly based on a national pharmacy claims database. Age Ageing 2006, 35(6):633-636. 10.1093/ageing/afl106, 17047009.
14. Irish Medicines Formulary Irish medicines formulary report 2012, Ireland: Selected Issues, Dublin 2012, Irish Medicines Formulary.
15. WHO Collaborating Centre for Drug Statistics Methodology Anatomical Therapeutic Chemical (ATC) Classification Index 2007, Oslo: WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology.
16. Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham COI, Weisman MH, Jackson CG, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006, 354(8):795-807. 10.1056/NEJMoa052771, 16495392.
17. Sibbritt D, Adams J, Lui CW, Broom A, Wardle J. Who uses glucosamine and why? A study of 266,848 Australians aged 45 years and older. PloS One 2012, 7(7):e41540. 10.1371/journal.pone.0041540, 3408465, 22859995.
18. NSAIDs and analgesics national charts. http://www.nhsbsa.nhs.uk/PrescriptionServices/2585.aspx.
19. Carlsen B, Glenton C, Pope C. Thou shalt versus thou shalt not: a meta-synthesis of GPs' attitudes to clinical practice guidelines. B J Gen Pract 2007, 57(545):971-978.
20. Barry M. Economic evaluation of glucosamine sulfate (DONA®) for the treatment of osteoarthritis in the Irish Healthcare setting. http://www.ncpe.ie/wp-content/uploads/2009/07/Economic-evaluation-of-glucosamine-sulphate-summary.pdf.
21. Bishop F, Lewith G. Who uses CAM? A narrative review of demographic characteristics and health factors associated with CAM use. Evid Based Complement Alternat Med 2010, 7(1):11-28. 10.1093/ecam/nen023, 2816378, 18955327.
22. Chung V, Ma P, Lau C, Wong S, Yeoh E, Griffiths S. Views on traditional Chinese medicine amongst Chinese population: a systematic review of qualitative and quantitative studies. Health Expect 2012, in press.
23. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008, 10(12):1-23.
24. Wazaify M, Shields E, Hughes CM, McElnay JC. Societal perspectives on over-the-counter (OTC) medicines. Fam Pract 2005, 22(2):170-176. 10.1093/fampra/cmh723, 15710640.
25. Tsui T, Boon H, Boecker A, Kachan N, Krahn M. Understanding the role of scientific evidence in consumer evaluation of natural health products for osteoarthritis an application of the means end chain approach. BMC Complement Altern Med 2012, 12(1):198. 10.1186/1472-6882-12-198, 3517436, 23107559.